Siga Technologies (SIGA) Cash from Operations (2010 - 2025)
Siga Technologies (SIGA) posted Cash from Operations of 9814444.0 for Q3 2025, down 115.56% on a QoQ basis from 63084829.0 in Q2 2025, and down 32.92% year-over-year from 14631941.83 in Q3 2024.
Siga Technologies (SIGA) Cash from Operations (2010 - 2025) Analysis & Trends
Siga Technologies' Cash from Operations history runs 16 years deep, the most recent figure standing at 9814444.0 for Q3 2025.
- Quarterly Cash from Operations fell 32.92% year-over-year to 9814444.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 116642361.0 (up 63.17% YoY) and the FY2024 annual result came in at 48761807.0, down 48.56% from the prior year.
- Cash from Operations was 9814444.0 for Q3 2025 at Siga Technologies, down from 63084829.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 79031730.0 in Q4 2023 and bottomed at 9814444.0 in Q3 2025.
- A 5-year average of 13526268.26 and a median of 1430272.0 in 2021 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 1279.83% in 2022, while the deepest fall reached 393.58% in 2022.
- Siga Technologies' Cash from Operations stood at 16102562.0 in 2021, then plunged by 150.34% to 8106225.0 in 2022, then surged by 1074.95% to 79031730.0 in 2023, then decreased by 28.75% to 56310100.0 in 2024, then plunged by 117.43% to 9814444.0 in 2025.
- Business Quant data shows SIGA's Cash from Operations at 9814444.0 in Q3 2025, 63084829.0 in Q2 2025, and 7061876.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -9.81 Mn |
| Sep 30, 2025 | -9.81 Mn |
| Jun 30, 2025 | 63.08 Mn |
| Jun 30, 2025 | 63.08 Mn |
| Mar 31, 2025 | 7.06 Mn |
| Mar 31, 2025 | 7.06 Mn |
| Dec 31, 2024 | 56.31 Mn |
| Dec 31, 2024 | 56.31 Mn |
| Sep 30, 2024 | -7.38 Mn |
| Sep 30, 2024 | -7.38 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | -6.12 Mn |
| Mar 31, 2024 | -6.12 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -3.58 Mn |
| Jun 30, 2023 | -3.58 Mn |